A more recent version of this article appeared on September 14, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 89/6/488    most recent hh1801.096337v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seasholtz, T. M. Articles by Brown, J. H. Search for Related Content PubMed Articles by Seasholtz, T. M. Articles by Brown, J. H. Related Collections Cell signalling/signal transduction Hypertension - basic studies Smooth muscle proliferation and differentiation

© 2001 American Heart Association, Inc.

Article

Increased Expression and Activity of RhoA Are Associated With Increased DNA Synthesis and Reduced p27^Kip1 Expression in the Vasculature of Hypertensive Rats

Tammy M. Seasholtz, Tong Zhang, Michael R. Morissette, Amy L. Howes, Amy H. Yang Joan Heller Brown

From the University of California, San Diego, Department of Pharmacology, La Jolla.

Correspondence to Joan Heller Brown, University of California, San Diego, Department of Pharmacology, 9500 Gilman Dr, La Jolla, CA 92093-0636. E-mail jhbrown{at}ucsd.edu

Abstract — We have previously shown that the function of the small G protein Rho is required for vascular smooth muscle cell proliferation and migration. We hypothesized that changes in Rho or Rho signaling might contribute to enhanced vascular proliferative responses associated with hypertension. Western blot analysis revealed that total RhoA expression was 2-fold higher in aortas, tail arteries, and aortic smooth muscle cells (ASMCs) obtained from adult male spontaneously hypertensive rats (SHR) compared with those from Wistar Kyoto rats (WKY). An increase in active GTP-bound RhoA was detected in aortic homogenates by affinity precipitation with the RhoA effector rhotekin and by examining RhoA-[³⁵S]GTPS binding. RhoA protein and activity were also increased in vessels from rats treated with N-nitro-L-arginine methyl ester to increase blood pressure. Thrombin-stimulated RhoA activation was also significantly greater in ASMCs from SHR. As a functional correlate of these changes in Rho signaling, thrombin-stimulated DNA synthesis was enhanced in tail arteries and ASMCs from SHR. Expression of the cyclin-dependent kinase inhibitor p27^Kip1 was decreased by two thirds in SHR, and this decrease was mimicked in ASMCs by expression of a constitutively active (GTPase-deficient) mutant of RhoA. Wortmannin (10 nmol/L) fully inhibited the decrease in p27^Kip1 induced by RhoA, and a membrane-targeted catalytic subunit of phosphatidylinositol-3 kinase (PI3K [p110_CAAX]) decreased p27^Kip1 expression, suggesting that RhoA signals through PI3K. These data provide evidence that RhoA brings about changes in DNA synthesis through reduced expression of p27^Kip1, mediated in part via PI3K, and suggest that increases in RhoA expression and activity contribute to the enhanced vascular responsiveness observed in hypertension.

Key Words: vascular smooth muscle • spontaneously hypertensive rats • Rho • p27^Kip1 • DNA synthesis

This article has been cited by other articles:

				C. Guilluy, S. Eddahibi, C. Agard, C. Guignabert, M. Izikki, L. Tu, L. Savale, M. Humbert, E. Fadel, S. Adnot, et al. RhoA and Rho Kinase Activation in Human Pulmonary Hypertension: Role of 5-HT Signaling Am. J. Respir. Crit. Care Med., June 15, 2009; 179(12): 1151 - 1158. [Abstract] [Full Text] [PDF]

				M. Moustafa-Bayoumi, M. A. Alhaj, O. El-Sayed, S. Wisel, M. A. Chotani, Z. A. Abouelnaga, M. D. H. Hassona, K. Rigatto, M. Morris, G. Nuovo, et al. Vascular Hypertrophy and Hypertension Caused by Transgenic Overexpression of Profilin 1 J. Biol. Chem., December 28, 2007; 282(52): 37632 - 37639. [Abstract] [Full Text] [PDF]

				D. P. Del Re, S. Miyamoto, and J. H. Brown RhoA/Rho Kinase Up-regulate Bax to Activate a Mitochondrial Death Pathway and Induce Cardiomyocyte Apoptosis J. Biol. Chem., March 16, 2007; 282(11): 8069 - 8078. [Abstract] [Full Text] [PDF]

				B. S. Zuckerbraun, D. A. Stoyanovsky, R. Sengupta, R. A. Shapiro, B. A. Ozanich, J. Rao, J. E. Barbato, and E. Tzeng Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA Am J Physiol Cell Physiol, February 1, 2007; 292(2): C824 - C831. [Abstract] [Full Text] [PDF]

				J. H. Lee and L. Ragolia AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1355 - C1365. [Abstract] [Full Text] [PDF]

				Y. Goueffic, C. Guilluy, P. Guerin, P. Patra, P. Pacaud, and G. Loirand Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation Cardiovasc Res, November 1, 2006; 72(2): 339 - 348. [Abstract] [Full Text] [PDF]

				S. Chrissobolis and C. G. Sobey Recent Evidence for an Involvement of Rho-Kinase in Cerebral Vascular Disease Stroke, August 1, 2006; 37(8): 2174 - 2180. [Abstract] [Full Text] [PDF]

				C. V. Garat, D. Fankell, P. F. Erickson, J. E.-B. Reusch, N. N. Bauer, I. F. McMurtry, and D. J. Klemm Platelet-Derived Growth Factor BB Induces Nuclear Export and Proteasomal Degradation of CREB via Phosphatidylinositol 3-Kinase/Akt Signaling in Pulmonary Artery Smooth Muscle Cells. Mol. Cell. Biol., July 1, 2006; 26(13): 4934 - 4948. [Abstract] [Full Text] [PDF]

				Y. Zeng, S. Zhuang, J. Gloddek, C.-C. Tseng, G. R. Boss, and R. B. Pilz Regulation of cGMP-dependent Protein Kinase Expression by Rho and Kruppel-like Transcription Factor-4 J. Biol. Chem., June 23, 2006; 281(25): 16951 - 16961. [Abstract] [Full Text] [PDF]

				B. Wojciak-Stothard, L. Y. F. Tsang, E. Paleolog, S. M. Hall, and S. G. Haworth Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1173 - L1182. [Abstract] [Full Text] [PDF]

				T. M. Seasholtz, J. Wessel, F. Rao, B. K. Rana, S. Khandrika, B. P. Kennedy, E. O. Lillie, M. G. Ziegler, D. W. Smith, N. J. Schork, et al. Rho Kinase Polymorphism Influences Blood Pressure and Systemic Vascular Resistance in Human Twins: Role of Heredity Hypertension, May 1, 2006; 47(5): 937 - 947. [Abstract] [Full Text] [PDF]

				J. H. Brown, D. P. Del Re, and M. A. Sussman The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits Circ. Res., March 31, 2006; 98(6): 730 - 742. [Abstract] [Full Text] [PDF]

				G. Loirand, P. Guerin, and P. Pacaud Rho Kinases in Cardiovascular Physiology and Pathophysiology Circ. Res., February 17, 2006; 98(3): 322 - 334. [Abstract] [Full Text] [PDF]

				Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF]

				J. Crespo, J. Martinez-Gonzalez, J. Rius, and L. Badimon Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation Cardiovasc Res, August 1, 2005; 67(2): 333 - 341. [Abstract] [Full Text] [PDF]

				B. T. Andresen, K. Shome, E. K. Jackson, and G. G. Romero AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity Am J Physiol Renal Physiol, April 1, 2005; 288(4): F763 - F770. [Abstract] [Full Text] [PDF]

				H. Nishimatsu, E. Suzuki, H. Satonaka, R. Takeda, M. Omata, T. Fujita, R. Nagai, T. Kitamura, and Y. Hirata Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1770 - H1776. [Abstract] [Full Text] [PDF]

				G. Loirand, M. Rolli-Derkinderen, and P. Pacaud RhoA and resistance artery remodeling Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1051 - H1056. [Abstract] [Full Text] [PDF]

				Z. Zhu, S. Zhu, D. Liu, T. Cao, L. Wang, and M. Tepel Thiazide-Like Diuretics Attenuate Agonist-Induced Vasoconstriction by Calcium Desensitization Linked to Rho Kinase Hypertension, February 1, 2005; 45(2): 233 - 239. [Abstract] [Full Text] [PDF]

				T. M. Seasholtz and J. H. Brown RHO SIGNALING in Vascular Diseases Mol. Interv., December 1, 2004; 4(6): 348 - 357. [Abstract] [Full Text] [PDF]

				S. Seibold, D. Schurle, A. Heinloth, G. Wolf, M. Wagner, and J. Galle Oxidized LDL Induces Proliferation and Hypertrophy in Human Umbilical Vein Endothelial Cells via Regulation of p27Kip1 Expression: Role of RhoA J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3026 - 3034. [Abstract] [Full Text] [PDF]

				Y. Liu, Y. J. Suzuki, R. M. Day, and B. L. Fanburg Rho Kinase-Induced Nuclear Translocation of ERK1/ERK2 in Smooth Muscle Cell Mitogenesis Caused by Serotonin Circ. Res., September 17, 2004; 95(6): 579 - 586. [Abstract] [Full Text] [PDF]

				S. Albinsson, I. Nordstrom, and P. Hellstrand Stretch of the Vascular Wall Induces Smooth Muscle Differentiation by Promoting Actin Polymerization J. Biol. Chem., August 13, 2004; 279(33): 34849 - 34855. [Abstract] [Full Text] [PDF]

				K. Budzyn, P. D. Marley, and C. G. Sobey Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R342 - R348. [Abstract] [Full Text] [PDF]

				V. Andres Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential Cardiovasc Res, July 1, 2004; 63(1): 11 - 21. [Abstract] [Full Text] [PDF]

				K. Bailly, A. J. Ridley, S. M. Hall, and S. G. Haworth RhoA Activation by Hypoxia in Pulmonary Arterial Smooth Muscle Cells Is Age and Site Specific Circ. Res., May 28, 2004; 94(10): 1383 - 1391. [Abstract] [Full Text] [PDF]

				I. Plavec, O. Sirenko, S. Privat, Y. Wang, M. Dajee, J. Melrose, B. Nakao, E. Hytopoulos, E. L. Berg, and E. C. Butcher Method for analyzing signaling networks in complex cellular systems PNAS, February 3, 2004; 101(5): 1223 - 1228. [Abstract] [Full Text] [PDF]

				K. Ito, Y. Hirooka, T. Kishi, Y. Kimura, K. Kaibuchi, H. Shimokawa, and A. Takeshita Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hypertension Caused by Chronic Nitric Oxide Synthase Inhibition Hypertension, February 1, 2004; 43(2): 156 - 162. [Abstract] [Full Text] [PDF]

				V. Sauzeau, M. Rolli-Derkinderen, S. Lehoux, G. Loirand, and P. Pacaud Sildenafil Prevents Change in RhoA Expression Induced by Chronic Hypoxia in Rat Pulmonary Artery Circ. Res., October 3, 2003; 93(7): 630 - 637. [Abstract] [Full Text] [PDF]

				A. P. SOMLYO and A. V. SOMLYO Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase Physiol Rev, October 1, 2003; 83(4): 1325 - 1358. [Abstract] [Full Text] [PDF]

				M. M. Chou, J. M. Masuda-Robens, and M. L. Gupta Cdc42 Promotes G1 Progression through p70 S6 Kinase-mediated Induction of Cyclin E Expression J. Biol. Chem., September 12, 2003; 278(37): 35241 - 35247. [Abstract] [Full Text] [PDF]

				B. S. Zuckerbraun, R. A. Shapiro, T. R. Billiar, and E. Tzeng RhoA Influences the Nuclear Localization of Extracellular Signal-Regulated Kinases to Modulate p21Waf/Cip1 Expression Circulation, August 19, 2003; 108(7): 876 - 881. [Abstract] [Full Text] [PDF]

				K. Ito, Y. Hirooka, K. Sakai, T. Kishi, K. Kaibuchi, H. Shimokawa, and A. Takeshita Rho/Rho-Kinase Pathway in Brain Stem Contributes to Blood Pressure Regulation via Sympathetic Nervous System: Possible Involvement in Neural Mechanisms of Hypertension Circ. Res., June 27, 2003; 92(12): 1337 - 1343. [Abstract] [Full Text] [PDF]

				V. Sauzeau, M. Rolli-Derkinderen, C. Marionneau, G. Loirand, and P. Pacaud RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase Activation J. Biol. Chem., March 7, 2003; 278(11): 9472 - 9480. [Abstract] [Full Text] [PDF]

				T. Seko, M. Ito, Y. Kureishi, R. Okamoto, N. Moriki, K. Onishi, N. Isaka, D. J. Hartshorne, and T. Nakano Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle Circ. Res., March 7, 2003; 92(4): 411 - 418. [Abstract] [Full Text] [PDF]

				A. M. Hopkins, S. V. Walsh, P. Verkade, P. Boquet, and A. Nusrat Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function J. Cell Sci., February 15, 2003; 116(4): 725 - 742. [Abstract] [Full Text] [PDF]

				C. Barandier, X.-F. Ming, and Z. Yang Small G Proteins as Novel Therapeutic Targets in Cardiovascular Medicine Physiology, February 1, 2003; 18(1): 18 - 22. [Abstract] [Full Text] [PDF]

				Z. Guo, W. Su, Z. Ma, G. M. Smith, and M. C. Gong Ca2+-independent Phospholipase A2 Is Required for Agonist-induced Ca2+ Sensitization of Contraction in Vascular Smooth Muscle J. Biol. Chem., January 10, 2003; 278(3): 1856 - 1863. [Abstract] [Full Text] [PDF]

				H. Wang, J. J. Ubl, R. Stricker, and G. Reiser Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1351 - C1364. [Abstract] [Full Text] [PDF]

				F. R. Danesh, M. M. Sadeghi, N. Amro, C. Philips, L. Zeng, S. Lin, A. Sahai, and Y. S. Kanwar 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy PNAS, June 11, 2002; 99(12): 8301 - 8305. [Abstract] [Full Text] [PDF]